Disclosure Of Interests In Other Entities [Text Block]

BerGenBio - Filing #2581090

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
166,663,000 NOK
449,045,000 NOK
Non-current assets
43,000 NOK
1,191,000 NOK
Current liabilities
77,933,000 NOK
64,868,000 NOK
Non-current liabilities
275,000 NOK
942,000 NOK
Revenue
389,000 NOK
774,000 NOK
Profit (loss)
302,122,000 NOK
302,122,000 NOK
309,364,000 NOK
309,364,000 NOK
Comprehensive income
0 NOK
302,606,000 NOK
302,606,000 NOK
0 NOK
309,476,000 NOK
0 NOK
0 NOK
309,476,000 NOK
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
150,803,000 NOK
436,646,000 NOK
721,641,000 NOK
Tax expense (income)
0 NOK
0 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.